Monthly Archives: July 2026

Event Date: July 25, 2026
Start Time: 12:30 PM
Venue: Lezzet Restaurant
Location: Erbil, Iraq

XenoFarma successfully organized a scientific Round Table Discussion on July 25, 2026, bringing together a distinguished group of gynecologists in Erbil to discuss evidence-based approaches for advancing women’s health and reproductive care.

The meeting focused on contemporary strategies for the management of female subfertility, vulvovaginal lesions, and restoration of the vaginal mucosal ecosystem, highlighting innovative therapeutic options designed to improve clinical outcomes and patient quality of life.

The scientific program featured discussions on three key therapeutic solutions:

• Ginfast FRT®, presented as an evidence-based option to support hormonal balance, ovulation, and oocyte quality in women undergoing subfertility management.
• Silver Care® Spray & Cream, an advanced silver-ion formulation designed to provide antimicrobial protection while supporting tissue repair and post-procedural healing in vulvovaginal lesions.
• Fluginol®, a targeted non-hormonal formulation developed to help restore vaginal pH, relieve mucosal dryness, and reduce irritation, thereby supporting vaginal health and comfort.

The round table encouraged active participation and scientific dialogue, enabling attendees to exchange clinical experiences and discuss practical applications of these therapeutic approaches in routine gynecological practice.

Through educational initiatives such as this, XenoFarma continues to support continuous medical education and strengthen collaboration with healthcare professionals by promoting innovative, evidence-based solutions that contribute to improved women’s health.

Event Date: July 23, 2026
Start Time: 1:00 PM
Venue: Lezzet Restaurant
Location: Iraq

XenoFarma successfully organized a Scientific Meeting for Family Medicine Specialists on July 23, 2026, reaffirming its commitment to supporting evidence-based medical education and fostering meaningful scientific collaboration among healthcare professionals.

The meeting brought together family medicine physicians for an engaging educational program featuring three scientific sessions that addressed important topics in primary healthcare and preventive medicine.

Scientific Program

1. Geriatric Health
Presented by: Dr. Amer A. Dhiab, Consultant Physician in Family Medicine (MBChB, FICMS/FM)

The session explored contemporary approaches to healthy aging, emphasizing comprehensive assessment, preventive strategies, and patient-centered management of common health conditions affecting older adults.

2. Novel Phytotherapeutic Management for Pediatric Renal and Urinary Tract Disorders
Presented by: Ph. Rawand Sirwan Izzalddin, B.Sc., M.Sc. in Pharmaceutical Technology

This presentation reviewed emerging evidence supporting phytotherapeutic interventions in pediatric renal and urinary tract disorders, highlighting their role as supportive therapeutic options within evidence-based clinical practice.

3. Effects of Probiotics on Gut Microbiota: An Overview
Presented by: Ph. Dyar Mudhafar Salman, B.Sc., M.Sc. in Clinical Pharmacy

The final session discussed the strain-specific effects of probiotics on gut microbiota, examining their contribution to maintaining gastrointestinal health and their potential role in supporting overall patient well-being.

The meeting concluded with an interactive scientific discussion, providing participants with an opportunity to exchange clinical experiences and explore practical applications of current evidence in family medicine.

XenoFarma remains dedicated to strengthening partnerships with healthcare professionals and supporting high-quality educational initiatives that contribute to improved clinical practice and better patient care.

Our focus is our strength.

Event Date: July 21, 2026
Start Time: 12:30 PM
Venue: Hardi Restaurant
Location: Halabja, Sulaymaniyah, Iraq

On July 21, 2026, XenoFarma successfully organized a specialized scientific meeting at Hardi Restaurant in Halabja, bringing together a distinguished group of internists, endocrinologists, and gynecologists to discuss contemporary approaches to the management of Type 2 Diabetes Mellitus.

The scientific session focused on the challenges of glycemic control, with particular emphasis on postprandial hyperglycemia and its role in the long-term progression of diabetes and its complications. Participants reviewed current evidence on the importance of controlling postprandial glucose excursions as part of a comprehensive diabetes management strategy.

A key topic of the meeting was “A Novel Approach to Postprandial Glycemic Management: The Role of Reversible α-Glucosidase Inhibition in Controlling Glycemic Spikes.” The discussion explored the physiological basis of reversible α-glucosidase inhibition and its contribution to reducing postprandial glucose fluctuations while supporting overall metabolic control.

The session also highlighted the clinical role of Glicoper D®, an Italian phytotherapeutic product from Erbozeta, as a safe and effective option for supporting Type 2 Diabetes Mellitus management and improving postprandial glycemic control. Participants engaged in an interactive scientific discussion, exchanging clinical experiences and practical perspectives on integrating evidence-based phytotherapy into routine diabetes care.

Through such educational initiatives, XenoFarma continues to promote continuous medical education and support healthcare professionals with innovative, evidence-based therapeutic solutions.

Event Date: July 18, 2026

XenoFarma successfully organized a specialized scientific meeting on July 18, 2026, bringing together a distinguished group of radiotherapists to discuss important gastrointestinal considerations encountered during radiotherapy treatment.

The session focused on evidence-based approaches to optimizing gastrointestinal care before and during radiotherapy. Particular attention was given to the clinical role of PURGOTEC® in bowel preparation and rectal evacuation, especially in patients undergoing prostate radiotherapy, where appropriate bowel management contributes to treatment accuracy and patient comfort.

The meeting also highlighted the benefits of TRIO-ZYME® in the management of common gastrointestinal symptoms, including dyspepsia, bloating, indigestion, and occasional acidity. The discussion reviewed practical considerations for supporting digestive health and improving patient comfort throughout the course of treatment.

The session encouraged active scientific discussion and exchange of clinical experience among participants, providing an opportunity to review practical strategies that can be incorporated into routine radiotherapy practice.

XenoFarma remains committed to supporting continuous medical education and advancing multidisciplinary collaboration through scientific meetings that promote evidence-based patient care and improved clinical outcomes.

Event Date: June 29, 2026
Start Time: 9:00 AM
Venue: Emergency Hospital for Trauma and Burn
City: Erbil, Iraq

A specialized Round Table Discussion titled “Advanced Drug Delivery in Wound Management & Neuro-Regenerative Protocols” was successfully held on June 29, 2026, at the Emergency Hospital for Trauma and Burn in Erbil. The meeting brought together clinicians working in emergency, trauma, and burn care to discuss emerging innovations in the management of complex injuries.

The scientific session focused on the evolving role of Advanced Drug Delivery Systems (ADDS) in wound management, highlighting modern approaches designed to improve targeted drug delivery, support tissue repair, and optimize post-traumatic recovery. Participants also explored the growing field of neuro-regenerative protocols, reviewing current concepts and their potential contribution to improving functional recovery following traumatic injuries.

The interactive round table encouraged scientific dialogue and the exchange of clinical experience, allowing participants to discuss practical applications of these emerging technologies in emergency medicine and trauma care.

XenoFarma remains committed to supporting continuous medical education by facilitating high-quality scientific meetings that promote innovation, evidence-based practice, and multidisciplinary collaboration across Iraq.